115 related articles for article (PubMed ID: 38616063)
1. Value of long non-coding RNA HAS2-AS1 as a diagnostic and prognostic marker of glioma.
You A; Gu J; Wang J; Li J; Zhang Y; Rao G; Ge X; Zhang K; Gao X; Wang D
Neurologia (Engl Ed); 2024 May; 39(4):353-360. PubMed ID: 38616063
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and Prognostic Potentials of Long Noncoding RNA ELF3-AS1 in Glioma Patients.
Mei JC; Yan G; Mei SQ
Dis Markers; 2020; 2020():8871746. PubMed ID: 33014189
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients.
Yuan Q; Gao C; Lai XD; Chen LY; Lai TB
Dis Markers; 2020; 2020():8895968. PubMed ID: 33282010
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer.
Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1.
Wang J; Gu J; You A; Li J; Zhang Y; Rao G; Ge X; Zhang K; Li J; Liu X; Wang Q; Lin T; Cheng L; Zhu M; Wu X; Wang D
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776110
[TBL] [Abstract][Full Text] [Related]
6. HAS2-AS1 Acts as a Molecular Sponge for miR-137 and Promotes the Invasion and Migration of Glioma Cells by Targeting EZH2.
Wang J; Zhang Y; You A; Li J; Gu J; Rao G; Ge X; Zhang K; Fu H; Liu X; Li J; Wang Q; Wu X; Cheng L; Zhu M; Wang D
Cell Cycle; 2020 Nov; 19(21):2826-2835. PubMed ID: 33064966
[TBL] [Abstract][Full Text] [Related]
7. Silencing of HAS2-AS1 mediates PI3K/AKT signaling pathway to inhibit cell proliferation, migration, and invasion in glioma.
Zhao Z; Liang T; Feng S
J Cell Biochem; 2019 Jul; 120(7):11510-11516. PubMed ID: 30790335
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma.
Zhu G; Wang S; Chen J; Wang Z; Liang X; Wang X; Jiang J; Lang J; Li L
Mol Carcinog; 2017 Oct; 56(10):2210-2222. PubMed ID: 28485478
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
10. LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma.
Zhu X; Chen D; Sun Y; Yang S; Wang W; Liu B; Gao P; Li X; Wu L; Ma S; Lin W; Ma J; Yan D
BMC Cancer; 2023 Feb; 23(1):120. PubMed ID: 36747161
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
Zhang D; Zhou H; Liu J; Mao J
Biomed Res Int; 2019; 2019():5437531. PubMed ID: 30949502
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
[TBL] [Abstract][Full Text] [Related]
13. Up‑regulation of lncRNA PXN-AS1-L is associated with unfavorable prognosis in patients suffering from glioma.
Shang F; Du SW; Ma XL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8950-8955. PubMed ID: 31696482
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and diagnostic significance of long non-coding RNA AGAP2-AS1 levels in patients with non-small cell lung cancer.
Fan KJ; Liu Y; Yang B; Tian XD; Li CR; Wang B
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2392-2396. PubMed ID: 28617550
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma.
Gong W; Tian M; Qiu H; Yang Z
Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548
[TBL] [Abstract][Full Text] [Related]
16. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA HAS2-AS1 promotes tumor progression in glioblastoma via functioning as a competing endogenous RNA.
Zhang L; Wang H; Xu M; Chen F; Li W; Hu H; Yuan Q; Su Y; Liu X; Wuri J; Yan T
J Cell Biochem; 2020 Jan; 121(1):661-671. PubMed ID: 31385362
[TBL] [Abstract][Full Text] [Related]
19. Potential role of RAB6C-AS1 long noncoding RNA in different cancers.
Salavaty A; Motlagh FM; Barabadi M; Cheshomi H; Esmatabadi MJD; Shahmoradi M; Soleimanpour-Lichaei HR
J Cell Physiol; 2018 Jan; 234(1):891-903. PubMed ID: 30076712
[TBL] [Abstract][Full Text] [Related]
20. Identification of immune infiltration-related LncRNA FAM83C-AS1 for predicting prognosis and immunotherapy response in colon cancer.
Li G; Feng H; Chen Q; Xue C; Li M; Liu X; Ma S
Transpl Immunol; 2021 Dec; 69():101481. PubMed ID: 34624486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
